- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Evidence-Based Tuberculosis Diagnosis 英文参考文献
Research in Translation
Evidence-Based Tuberculosis Diagnosis
Madhukar Pai , Andrew Ramsay, Richard O’Brien
*
T
here is great excitement in the
tuberculosis (TB) scientific
community over the introduction
steps involved in the policy process
include a comprehensive review of the
evidence, as well as expert opinion
and judgment (Box 1).
High-quality evidence on TB
diagnostics is critical for the
in the latter setting. However, meta-
analyses on IGRAs have highlighted
the lack of evidence on the predictive
ability of these assays in identifying
those individuals with TB infection who
are at highest risk for progressing to
active disease. Several cohort studies
are ongoing (reviewed elsewhere
[39]), and these should provide useful
evidence on this unresolved issue.
For active TB, serological tests have
been attempted for decades. Two
meta-analyses have convincingly shown
that existing commercial antibody-
based tests have poor accuracy and
limited clinical utility [29,30]. Despite
this evidence, dozens of commercial
serological tests continue to be
of new tools into TB control activities.
The development of new tools is an
important component of the Global
Plan to Stop TB and the World
Health Organization’s new global
Stop TB Strategy [1,2]. Anticipating
the introduction of new tools, the
Stop TB Partnership has established
a Retooling Task Force to develop a
framework for engaging policy makers
to foster accelerated adoption and
implementation of new tools into TB
control programs [3].
While new tools offer great promise
in clinical medicine and in public
health, limited resources and the
movement toward evidence-based
guidelines and policies require careful
validation of new tools prior to their
introduction for routine use. The
world spends an estimated US$1
billion per year on diagnostics for
TB [4]. It is important to ensure that
such expenditure is backed by strong
evidence.
development of evidence-based policies
on TB diagnosis, and, ultimately, for
effectiv
您可能关注的文档
- Evaluation of Oxfendazole, Praziquantel and Albendazole against Cystic Echinococcosis A Randomized Clinical Trial in Naturally Infected Sheep 英文参考文献.doc
- Evaluation of Spatially Targeted Strategies to Control Non-Domiciliated Triatoma dimidiata Vector of Chagas Disease 英文参考文献.doc
- Evaluation of qPCR-Based Assays for Leprosy Diagnosis Directly in Clinical Specimens 英文参考文献.doc
- Evaluation of Social and Physical Enrichment in Modulation of Behavioural Phenotype in C57BL6J Female Mice 英文参考文献.doc
- Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin β-4 in the Dystrophin Deficient Mouse 英文参考文献.doc
- Evaluation of Serological Diagnostic Test Systems Assessing the Immune Response to Japanese Encephalitis Vaccination 英文参考文献.doc
- Evaluation of the 2007 WHO Guideline to Improve the Diagnosis of Tuberculosis in Ambulatory HIV-Positive Adults 英文参考文献.doc
- Evaluation of Targeted Influenza Vaccination Strategies via Population Modeling 英文参考文献.doc
- Evaluation of the Effect of Systolic Blood Pressure and Pulse Pressure on Cognitive Function The Women's Health and Aging Study II 英文参考文献.doc
- Evaluation of RTS,SAS02A and RTS,SAS01B in Adults in a High Malaria Transmission Area 英文参考文献.doc
文档评论(0)